✦ LIBER ✦

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

✍ Scribed by Bondarenko, Igor; Gladkov, Oleg A; Elsaesser, Reiner; Buchner, Anton; Bias, Peter

Book ID: 121628670
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 379 KB
Volume: 13
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-13-386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Morning Versus Ev

Efficacy and Safety of Morning Versus Evening Dose of Controlled-Release Simvastatin Tablets in Patients With Hyperlipidemia: A Randomized, Double-Blind, Multicenter Phase III Trial

✍ Kim, Sang-Hyun; Kim, Min-Kyung; Seo, Hong-Seok; Hyun, Min-Soo; Han, Kyoo-Rok; Ch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 265 KB

A multicenter, randomized, phase 2 clini

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

✍ Angeles Alvarez Secord; Andrew Berchuck; Robert V. Higgins; Lawrence R. Nycum; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Multicenter Phase III Randomized Trial C

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens

✍ Valero, V.; Forbes, J.; Pegram, M. D.; Pienkowski, T.; Eiermann, W.; von Minckwi 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB

Safety and Efficacy of Once-Daily Hydrom

Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study

✍ Yu, Shiying; Shen, Wei; Yu, Lu; Hou, Yanyan; Han, John; Richards, Henry M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 518 KB

Prospective randomized trial of 5-fluoro

Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control

✍ Jeffrey M. Albert; Aman U. Buzdar; Reina Guzman; Pamela K. Allen; Eric A. Strom; 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 240 KB

Randomized open-label non-comparative mu

Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study

✍ Auliac, J.B.; Chouaid, C.; Greiller, L.; Monnet, I.; Le Caer, H.; Falchero, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 484 KB